https://www.cancerresearchhorizons.com/ 2026-06-02T16:12:25+01:00 daily 1.0 https://www.cancerresearchhorizons.com/news-and-events/our-news/eacr-and-cancertoolsorg-sign-strategic-partnership-accelerate-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-dose-first-patient-phase-i/iia-trial-lung-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/takeda-acquire-adaptate-biotherapeutics-develop-novel-gamma-delta-gd-t 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-researchers-across-uk-join-forces-find-drugs-rare-cancers 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-presents-positive-clinical-data-esmo-io 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-announces-first-patient-dosed-trial-hard-treat-cancers 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/synconas-autolus-250m-funding-deal-blackstone-life-sciences 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-teon-therapeutics-announce-first-patient-dosed 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/takeda-acquire-cancer-research-uks-spinout-gammadelta-therapeutics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/monte-rosa-therapeutics-presents-preclinical-data-aacr-nci-eortc 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/hummingbird-bioscience-present-pre-clinical-data-novel-biomarkers-her3 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/artios-doses-first-patient-phase-1/2a-study-polth-inhibitor-art4215 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-partners-venture-builder-incubator-drive-innovation 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/carrick-therapeutics-presents-encouraging-initial-efficacy-samuraciclib-ct 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/gammadelta-therapeutics-initiates-first-human-phase-1-trial-gdx012 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/vaccine-treating-cancer-made-possible-using-oxford-covid-vaccine 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/innovative-icr-discovered-drug-enter-first-clinical-trial-targeting-hsf1 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/achilles-therapeutics-announces-grant-us-and-european-patents 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/innovative-cancer-spinouts-3-new-projects-get-green-light 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/carrick-therapeutics-announces-collaboration-roche-evaluate-novel 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/hummingbird-bioscience-announces-uk-mhra-approval-first-human-phase-1 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/birmingham-cancer-project-enters-immuno-oncology-alliance 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/artios-announces-153-million-ps110-million-series-c-financing-led-omega 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-announces-first-subject-dosed-healthy-volunteer-study-next 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/sitryx-licenses-intellectual-property-rights-inhibitors-new-target 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cruks-commercial-partnerships-team-publish-their-commitments-academic 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/university-birmingham-and-nonacus-partner-develop-urine-test-bladder 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/monte-rosa-therapeutics-announces-pricing-initial-public-offering 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/aleta-biotherapeutics-and-cancer-research-uk-collaborate-advance-blood 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/inivata-notes-completion-acquisition-neogenomics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/artios-pharma-publishes-preclinical-data-first-selective-small-molecule 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/kq-labs-announces-cancer-research-uk-new-strategic-partner-its-accelerator 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/achilles-therapeutics-details-phase-i/iia-clinical-trial-design-2021-asco 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-partners-medcity-collaborate-innovate-london 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uks-spinout-gammadelta-therapeutics-receives-fda-clearance 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uks-spinout-inivata-be-acquired-neogenomics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/adc-therapeutics-announces-fda-approval-zynlontatm 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/autolus-therapeutics-receives-innovation-passport-and-entry-ilap-auto4 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/adaptate-biotherapeutics-raises-18-million-series-a2-funding 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/valenzabio-advances-pipeline-antibody-therapeutics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/invitae-launches-full-access-its-liquid-based-personalized-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/artios-pharma-announces-collaboration-novartis-create-next-generation-ddr 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/singula-bio-provides-new-hope-cancer-diverse-individualised-therapies 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uks-spinout-achilles-therapeutics-announces-closing 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-tech-accelerator-programme-opens-drive-innovation-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-icr-spinout-company-monte-rosa-therapeutics-raises 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-reveals-innovation-engine-underpinned-ps400m-portfolio 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-forms-strategic-alliance-oncode-institute 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/leading-cancer-research-institute-partner-boehringer-ingelheim-advance 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/biocaptiva-announces-oversubscribed-ps21-million-additional-seed-financing 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/achilles-therapeutics-doses-first-patient-higher-dose-cnet-phase-i/iia 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/adc-therapeutics-announces-results-pivotal-phase-2-clinical-trial 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-stitch-partner-understand-and-improve-patient 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/pharmacia-upjohn-eio-and-crv-sign-agreement-discover-new-cancer-targets 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crv-leads-ec-technology-transfer-project 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/first-mammalian-lifespan-gene-isolated 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crusade-laboratories-ltd-developing-new-cancer-therapies-herpes-simplex 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crv-and-and-antisoma-plc-sign-license-agreement-novel-targeted-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crv-and-eio-explore-opportunities-discovery-first-mammalian-ageing-gene 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-campaign-technology-appoints-crv-exclusive-agent 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/qugen-therapeutics-new-gene-therapy-company-combining-technologies-uk-and 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/biotech-research-ventures-pte-ltd-launched 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crv-signs-exclusive-license-agreement-epigenomics-ag-berlin-germany 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/antisoma-licenses-dmxaa-promising-tumour-blood-vessel-targeting-agent 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/proacta-therapeutics-limited-new-company-developing-novel-treatment 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/collaboration-announced-identifying-new-inhibitors-against-hsp90-protein 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crv-ssigns-new-pre-clinical-candidate-auto-immune-disorders-and-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/exelixis-signs-non-exclusive-license-cancer-research-ventures-uk 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/mdm2-p53-cancer-pathway-targeted-multi-collaboration 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-formed-through-merger-cancer-research-ventures-and-imperial-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/rna-interference-explored-multi-collaboration 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/significant-milestone-route-designer-drugs-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/collaboration-announced-between-crt-university-newcastle-and-osi 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-alnylam-pharmaceuticals-inc-announce-alliance-rnai-technology 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-annouce-exclusive-license-glaxosmithkline 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-announces-appointment-dr-andy-richards-dr-celia-caulcott-non-exec 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/antisoma-licenses-telomerase-inhibitor-programme-crt 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/charity-make-breast-cancer-gene-brca2-gene-freely-available-across-europe 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/astex-wellcome-trust-institute-cancer-research-crt-announce-major-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/btg-takes-exclusive-licence-new-class-cancer-drug-crt-institute-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/scancell-secures-exclusive-worldwide-licence-agreement-crt-two-novel 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/kudos-pharmaceuticals-signs-agreements-university-cambridge-and-crt 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-grants-exclusive-license-genentech-patent-portfolio-oncology-target 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/institute-cancer-research-and-crt-make-european-brac2-gene-patent-freely 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/pharminox-ltd-signs-exclusive-agreement-crt 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-institute-cancer-research-complete-licence-vernalis 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/medical-solutions-plc-and-crt-develop-novel-toolkit-cancer-drug 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/marie-curie-cancer-care-and-crt-extend-relationship-cancer-patient-benefit 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-grants-astrazeneca-exclusive-license-key-patent-field-nuclear 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/sareum-announces-collaboration-crt 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/allos-therapeutics-licenses-new-cancer-compound 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/xenova-licenses-ta-cin-crt 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-announces-appointment-dr-phil-lhuillier-director-business-management 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/phogen-enters-technology-commercialisation-agreement-crt 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/astex-announces-new-drug-discovery-collaboration-university-newcastle-upon 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/pharminox-signs-option-license-novel-telomere-signalling-targeted-agents 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/novel-compounds-discovered-cancer-drug-discovery-collaboration 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-announce-colorectal-cancer-research-collaboration-astrazeneca 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-present-discovery-updates-bioeurope-2006 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-announce-milestone-following-initiation-stimuvaxr-phase-3-trial-non 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/progression-checkpoint-kinase-1-drug-discovery-programme 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/fox-chase-cancer-center-and-crt-inc-initiate-drug-discovery-collaboration 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-licenses-therapeutic-antibodies-peptech 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-licenses-novel-toll-receptor-agents-innate-pharma 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-licenses-colorectal-cancer-risk-technolgy 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/antisomas-asa404-lung-cancer-trial-will-report-positive-survival-data 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/breast-cancer-diagnostic-markers-licensed-perlegen-agreement-university 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-appoints-director-discovery 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-licenses-antibody-technology-glycart 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-astrazeneca-announce-innovative-deal-promising-anti 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-creates-crack-teams-solve-cancers-greatest-mysteries 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-opens-drug-discovery-laboratory-cambridge 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-selects-maybridge-fragments-lead-discovery-programmes 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-sosei-heptares-sign-agreement-advance-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/deep-science-ventures-and-cancer-research-horizons-amp-efforts-create 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/artios-initiates-phase-2-study-polth-inhibitor-art4215-combination-parp 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/hummingbird-bioscience-announces-trial-progress-poster-presentation 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/fierce-biotech-names-storm-therapeutics-one-its-fierce-15-biotech 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/monte-rosa-therapeutics-announces-fda-clearance-investigational-new-drug 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/aleta-biotherapeutics-receives-innovation-passport-designation-biologic 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-and-lean-life-science-launch-oncology-development 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/positive-phase-iii-clinical-trial-results-point-promise-capivasertib 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-and-newcastle-university-announce-alliance 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/precision-medicine-trial-opens-rare-adult-and-paediatric-cancers 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/monte-rosa-therapeutics-announces-first-patient-dosed-phase-1/2-clinical 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/storm-therapeutics-doses-first-patient-oral-mettl3-targeting-drug 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-and-karolinska-institutet-announce-5-year 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/achilles-therapeutics-presents-encouraging-phase-i/iia-update-clonal 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-initiates-phase-ib-pancreatic-cancer-trial-next-generation 2026-04-27T13:54:13+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/novartis-joins-cancer-research-uk-trial-rare-cancers 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/envisagenics-cancer-research-horizons-and-queen-mary-university-london 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/carrick-therapeutics-raises-60-million-through-series-c-and-pfizer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ideaya-biosciences-announces-submission-ind-application-us-fda-parg 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/storm-therapeutics-announces-closing-usd-30m-series-b-financing 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-awarded-eur175-million-funding-eic-accelerator-clinical 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/capivasertib-plus-faslodex-reduced-risk-disease-progression-or-death-40-0 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ai-powered-cancer-cell-simulations-will-be-used-identify-novel-disease 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-provides-development-update-first-class-semi-allosteric-pi3kd 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/adc-therapeutics-and-sobi-announce-european-commission-approval-zynlontar 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-and-singapores-experimental-drug-development 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/hummingbird-bioscience-exercises-its-option-license-clinical-trial-results 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-signs-multi-project-collaboration-ucb-advance-oncology 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/predictive-oncology-and-cancer-research-horizons-have-partnered-pursue 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/new-board-members-appointed-cancer-research-horizons-aims-step-change 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/leading-cancer-biologists-and-entrepreneurs-join-enedra-therapeutics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/personalis-joins-top-uk-cancer-research-organizations-evaluate-earlier 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ideaya-announces-first-patient-dosed-phase-1-clinical-trial-ide161 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/achilles-therapeutics-announces-grant-us-patent-covering-treatment 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/nuvectis-pharma-announces-initiation-phase-1b-study-nxp800-platinum 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-joins-european-precision-cancer-medicine-trial 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/twist-bioscience-and-cancer-research-horizons-enter-collaboration-advance 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/new-class-antibody-drug-shows-promise-cancer-patients 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/nkio-raises-ps12m-bringing-total-seed-funding-ps51m-advance-pioneering-nk 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/topline-phase-1-study-results-vac2-treatment-advanced-non-small-cell-lung 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/aleta-biotherapeutics-granted-mhra-clinical-trial-authorisation-biologic 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/sosei-heptares-and-cancer-research-uk-announce-dosing-first-patient-phase 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/sonrai-analytics-and-cancer-research-horizons-join-forces-drive-precision 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/year-growth-and-expansion-characterise-cancer-research-horizons-annual 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/uk-charities-team-empower-early-career-researchers 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-kwf-dutch-cancer-society-enter-partnership-bring 2026-05-27T15:47:36+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/truqap-capivasertib-plus-faslodex-approved-us-patients-advanced-hr 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-opens-nominations-its-innovation-entrepreneurship 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/enhanced-potential-myricxs-nmt-inhibitor-payloads-dual-senolytic-and 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-appoints-two-investors-residence-support-its 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-guardant-health-launch-collaboration-advance-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-appoints-new-director-lead-its-centre-drug-development 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/algok-bio-enters-exclusive-worldwide-license-agreement-btg-develop-and 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/carrick-therapeutics-announces-first-patient-dosed-phase-2b-clinical-trial 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/amplia-reports-first-patient-dosing-phase-2a-accent-trial 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-teon-therapeutics-advance-new-first-class-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/first-its-kind-clinical-trial-bring-hope-people-lung-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-icr-spinout-company-monte-rosa-therapeutics-0 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-university-southampton-and-touchlight-genetics-partner 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-abcam-launch-custom-partnership-accelerate-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/icr-and-cancer-research-uk-spinout-company-monte-rosa-therapeutics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/microbiotica-cancer-research-uk-and-cambridge-university-hospitals 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/repurposed-drug-tested-covid-19-trial-thanks-cancer-research-uk-know-how 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crescendo-biologics-and-cancer-research-uk-sign-clinical-development 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/start-codon-joins-cancer-research-uks-entrepreneurial-programmes 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-raises-eu15m-series-financing-progress-its-pipeline-clinical 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/bicycle-therapeutics-and-cancer-research-uk-collaborate-development-new 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/first-human-trial-new-lung-cancer-immunotherapy 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-lifearc-and-ono-pharmas-immunotherapy-alliance-wins 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/azeria-therapeutics-announces-ps32-million-series-b-financing 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-beatson-institute-starts-strategic-collaboration 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/adaptate-biotherapeutics-formed-develop-antibody-based-therapies-modulate 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-boosts-entrepreneurs-science 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-ono-pharmaceutical-and-lifearc-are-shortlisted-scrip 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/achilles-therapeutics-raises-ps100-million-oversubscribed-series-b 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-hummingbird-bioscience-join-forces-advance-novel 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/arxx-therapeutics-and-cancer-research-uk-announce-licence-agreement 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-forms-collaboration-sv-health-investors-accelerate 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/balversatm-gains-us-marketing-approval-following-early-discovery-work 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/aptamer-therapeutics-and-cancer-research-uk-announce-partnership-drug 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/autolus-therapeutics-raised-1008-million 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/inivata-completes-ps398-million-526m-series-b-round 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/fda-clearance-amplias-ind-pancreatic-cancer-trial-us 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-lifearc-and-ono-pharma-form-cancer-immunotherapy 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/fda-grants-full-approval-balversa-treat-locally-advanced-or-metastatic 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-astrazeneca-launch-world-class-functional-genomics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-francis-crick-institute-and-bristol-myers-squibb-join 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-innovation-summit 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/success-all-round-cancer-research-uk-supported-spinouts-obn-annual-awards 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uks-license-and-collaboration-partner-tusk-therapeutics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/carrick-therapeutics-licenses-targeted-ovarian-cancer-treatment-discovered 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-announces-new-chief-business-officer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-institute-cancer-research-london-join-forces-merck 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-announces-drug-discovery-collaboration-celgene 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/scancell-and-cancer-research-uk-collaborate-advance-novel-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/bicycle-therapeutics-and-cancer-research-uk-named-best-partnership 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/tumour-analysis-following-surgery-could-provide-breakthrough-predicting 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/glythera-licenses-novel-payload-class-cancer-research-uk-development-next 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-newcastle-university-extend-successful-multi 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-brings-commercialisation-arm-house 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-treatment-two-and-half-times-more-effective-when-tumours-have 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crts-discovery-laboratories-extends-alliance-merck-develop-new-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/merck-ventures-creates-new-immuno-oncology-company-ionctura 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/takeda-and-gammadelta-therapeutics-announce-collaboration-advance-tissue 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ucls-cancer-immunology-group-publishes-relevance-cd25-target-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-pioneer-fund-cancer-research-uk-and-nci-collaborate-boost-research 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/hitgen-and-cancer-research-uks-manchester-institute-enter-licence 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-ucl-and-tusk-therapeutics-join-forces-develop 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-pioneer-fund-and-cancer-research-uks-manchester-institute-nominate 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/mrc-technology-cancer-research-uk-and-cancer-research-technology 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-bicycle-therapeutics-have-collaborated-trial-new 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-pioneer-fund-announces-investment-blood-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-cancer-research-technology-partner-tyg-oncology 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-university-manchester-receive-success-payment-glaxosmithkline 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/achilles-therapeutics-launched-funds-ps132-million-develop-immunotherapies 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-pioneer-fund-licenses-oncology-drug-targeting-dna-damage-response 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-sv-life-sciences-form-artios-pharma-focus-dna-damage-response 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-alta-innovations-join-forces-commercialise-world-leading-research 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-and-pangaea-biotech-sign-license-agreement-new 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-university-copenhagen-announce-agreement-adc-therapeutics-develop 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-announces-license-agreement-msd-develop-inhibitors-prmt5-cancer-and 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/forma-therapeutics-and-crt-form-third-virtual-company-advance 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-cell-therapy-catapult-and-university-birmingham 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-appoints-deborah-harland-non-executive-director 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/nemucore-medical-innovations-options-clinical-stage-aurora-kinase 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-medimmune-launch-ground-breaking-biotherapeutics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-cancer-research-technology-announce-partnership 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/rd-alliance-restructure-presents-new-dna-damage-response-partnership 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-and-medivir-collaborate-develop-new-class 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/consortium-signs-deal-basilea-develop-resistance-busting-cancer-drugs 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-bioinvent-expand-collaboration-university-southampton-scientists 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/forma-therapeutics-and-crt-form-two-virtual-companies-advance 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/bioinvents-bi-1206-antibody-enter-collaborative-phase-i/ii-trial-funded 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/valneva-and-blink-therapeutics-confirm-launch-and-funding-blink-biomedical 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-crt-and-amgen-trial-leukaemia-immunotherapy-drug-other 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-pioneer-fund-banks-ps20m-investment-bacit-and-expands-agreement-chroma 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/three-new-companies-join-cancer-research-uk-abcodia-collaboration-identify 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-collaborate-astrazeneca-screening-new-cancer-medicines 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/bacit-seeks-shareholder-approval-commit-ps20m-and-join-crt-pioneer-fund 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ps50m-crt-pioneer-fund-announces-investment-develop-lung-cancer-drugs 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-leukaemia-lymphoma-research-team-boost-blood-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-medimmune-establish-joint-cruk-medi-alliance 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/inivata-raises-ps4m-realise-potential-ctdna-analysis-improve-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-cancer-research-technology-and-asterias-biotherapeutics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-cancer-research-technology-join-forces-astellas 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/promising-results-phase-1-trial-lead-immatics-continue-work-vaccine-ima950 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cyted-receives-510k-fda-clearance-endosignr-technology 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-tevas-collaboration-yields-successful-outcome-novel-apkc-protein 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-drug-launched-its-first-clinical-trial 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/successful-completion-phase-i-trial-gsk1070916 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/alchemia-announces-licensing-fak-inhibitors-crt 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/international-deal-screen-potential-cancer-drugs-using-dna-barcodes 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-astrazeneca-sign-deal-repurpose-asthma-drug-could 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-university-manchester-and-glaxosmithkline-work-together-generate-new 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/hitgen-announces-collaboration-drug-discovery-university-manchesters 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-and-nuevolution-sign-multi-target-deal-seek 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-pioneer-fund-collaborates-chroma-therapeutics-develop-cancer-drugs 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-pioneer-fund-bacit-and-sareum-enter-agreement-fund-development-drugs 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-teva-pharmaceuticals-form-rd-alliance-cancer-dna-damage-response 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-institute-cancer-research-and-merck-serono-sign-wnt-licensing-deal 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/forma-therapeutics-and-crt-discover-cancer-drugs-targeting 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-university-manchester-and-astrazeneca-work-together-seek-new-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-crt-collaborate-abcodia-discover-and-develop-tests 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-launches-trial-potential-new-drug-block-cancer-cells 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ps50m-crt-pioneer-fund-announces-first-investment-develop-cancer-drugs 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-icr-enter-collaboration-janssen-discover-multiple-myeloma-drug 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-astrazeneca-expand-successful-multi-project-cancer-metabolism 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/alliance-translational-research-centres-established-accelerate-global-drug 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-takes-investigational-multi-cancer-drug-laboratory 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/launch-trial-master-switch-drug-treat-several-cancer-types 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-crt-lease-new-chemistry-facilities-babraham 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-lorus-co-develop-first-kind-drug-il-17e-treat-solid 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/astex-pharmaceuticals-crt-and-newcastle-university-sign-strategic-drug 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-astex-pharmaceuticals-and-icr-announce-epigenetic-drug-discovery 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-adc-therapeutics-join-forces-antibody-drug-conjugates 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-and-bioinvent-enter-oncology-collaboration 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-eif-unveil-innovative-ps50m-cancer-fund-bridge-development-gap-uk 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-unveils-screen-test-potential-drugs-treat-oestrogen-positive-breast 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-spins-out-company-develop-cancer-surgery-machine-melt-tumours 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-cancer-research-uk-establish-lipid-metabolism-research-team 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/mission-therapeutics-new-spin-out-secures-ps6m-series-funding-led 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-kurma-biofund-develop-new-antibody-platform-translational-research 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cdp-signs-deal-centella-therapeutics-inc-launch-development-radiotherapy 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-and-affitech/s-sign-exclusive-antibody 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/senectus-therapeutics-and-astrazeneca-collaborate-identify-triggers-cell 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-icr-and-zobio-bv-sign-deal-develop-cancer-drugs 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/agreement-reached-identify-predictive-biomarker-parp-inhibitor-therapies 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-technology-and-cancer-research-uk-establish-team-stem-cell 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-astrazeneca-collaborate-trial-combinations-new 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-immatics-biotechnologies-launch-trial-brain-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-astrazeneca-sign-deal-trial-first-kind-cancer-drug 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-bayer-schering-investigate-new-therapeutic-approach-gynaecological 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-valirx-sign-licensing-deal-develop-prostate-cancer-treatment 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/antibody-licence-agreement-scancell-holdings-plc 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/carrick-therapeutics-announces-first-patient-dosed-phase-1b/2-clinical 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/skills-swap-exploit-expertise-patient-benefit 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/uk-nz-collaboration-home-new-anti-cancer-drug-leukaemia 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-announces-partnership-cephalon-develop-new-class-anti-cancer-drugs 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-immatics-biotechnologies-trial-vaccine-brain-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-and-astrazeneca-form-major-alliance-create-cancer-metabolism-drugs 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/development-deal-pkb-inhibitor-announced 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/deal-struck-new-investigational-anti-cancer-drug-target-leukaemia-and 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-grants-rights-targeting-technology-aura 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/scientists-scoop-top-prize-light-based-detection-technology 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-licence-telomere-targeting-agents-pharminox-drug-development 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-facilitates-collaboration-between-duke-university-and-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-astrazeneca-accelerate-biomarker-research 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/new-alliance-discovery-wnt-pathway-inhibitors-be-used-cancer-therapy 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/initiation-global-phase-iii-clinical-study-merck-kgaa-stimuvaxr 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/innovative-partnership-targets-cancer-causing-chaperones 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cambridge-research-institute-attracts-gsk-backing-novel-therapeutic 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-glaxosmithkline-join-forces-trial-new-anti-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-newcastle-university-and-kudos-advance-dna-pk-research-new-licence 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/potential-new-drug-blocks-pathway-deadliest-cancers 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/new-deal-boosts-development-targeting-peptides-nanotechnology 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/temozolomide-sales-reach-1-billion 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/dr-melanie-lee-chairman-crt-awarded-commander-order-british-empire-cbe 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cymap-deal-puts-new-generation-technology-focus 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-astex-therapeutics-join-forces-develop-new-anti 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/crt-licenses-colorectal-cancer-risk-technology 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/valirx-acquires-global-rights-novel-compound-targeted-prostate-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/vernalis-receives-milestone-payment-hsp90-inhibitor-collaboration 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/new-ceo-spearhead-laboratory-expansion-crt-0 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/aleta-biotherapeutics-and-cancer-research-uks-centre-drug-development 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/neobe-therapeutics-raises-over-2m-synthetic-biology-enabled-tumour 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/artificial-intelligence-reveals-prostate-cancer-not-just-one-disease 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/us-fda-grants-orphan-drug-designation-ioncturas-first-class-autotaxin 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-volt-open-squamous-oesophageal-cancer-cohort 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-norwegian-cancer-society-enter-partnership-broaden 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/empowering-innovation-cancer-research-horizons-recognises-trailblazers 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/integrated-cancer-biotech-infinitopes-secures-ps128m-seed-financing 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/achilles-therapeutics-announces-research-collaboration-arcturus 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/monte-rosa-therapeutics-raises-100m-follow-funding 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/us-fda-approves-akeegatm-niraparib-and-abiraterone-acetate-first-and-only 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-announces-eu80m-series-b-financing-progress-pipeline-through 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-and-merck-kgaa-darmstadt-germany-have-expanded 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/myricx-bio-announces-ps90m-114m-series-financing-advance-its-novel-nmti 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/pelago-bioscience-ab-signs-strategic-agreement-cancer-research-horizons 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-announces-expansion-roginolisib-clinical-trial-programme-nsclc 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-and-deep-science-ventures-create-new 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-appoints-therapeutic-innovation-board-drive-drug 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-announces-dosing-first-patient-phase-2-trial 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-events/Cancer-Research-Horizons-announce-extension-of-partnership-with-AstraZeneca-on-the-Functional-Genomics-Centre 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-events/Cancer-Research-Horizons-and-LifeArc-launch-C-Further-an-international-consortium-aiming-to-remove-barriers-to-childhood-cancers-therapeutics-development 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-launches-start-suil-vision-develop-virtual 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-present-phase-1/2a-clinical-trial-cancer-immunotherapy 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/verinnogen-secures-innovate-uk-grant 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/fda-fast-track-designation-granted-narmafotinib-pancreatic-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-novalgen-collaborate-advance-t-cell-engager-clinic 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-kisoji-partner-for-first-naked-antibody 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-announces-dosing-first-patient-UCB4594-trial 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/venture-builder-incubator-50-launches-expanded-cohort 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/infinitopes-showcase-breakthroughs-cancer-vaccine-development-sitc-2024 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/trogenix-unveils-revolutionary-platform-transform-cancer-treatment 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/storm-therapeutics-presents-new-clinical-data-at-SITC 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/landmark-pill-thread-cancer-screening-trial-welcomes-first-participants 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/52north-secures-6m-landmark-uk-us-hospital-vc-deal 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/oncode-accelerator-institute-cancer-research-horizons-alliance 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-brings-together-oncology-investors-and-innovators 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-and-diamond-light-source-establish-drug-discovery 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/garfield-weston-foundation-donates-ps10m-our-cancer-impact-booster 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-reaches-new-clinical-milestones-uveal-melanoma 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/collaborative-discovery-yields-promising-results-novel-mdm2-p53-antagonist 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/achilles-therapeutics-announces-sale-technology-assets-astrazeneca 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/precision-oncology-company-sentinal4d-completes-pre-seed-funding-round 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-opens-nominations-its-innovation-and 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/lung-cancer-test-predicts-survival-early-stages-better-current-methods 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-cytovation-and-norwegian-cancer-society-collaborate 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/protein-level-predicts-immunotherapy-response-bowel-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-partners-lifebit-maximise-impact-research-data 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-launches-cancer-impact-club-raise-ps5m 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-commences-randomised-phase-2-study-metastatic-uveal-melanoma 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/infinitopes-strengthens-board-two-biotech-leaders-advance-precision 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/52north-appoints-industry-leader-john-jeans-cbe-chair 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-partners-histofy-develop-ai-based-tools 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/akamis-bio-announces-enrollment-first-patient-phase-1b-fortress-trial-ng 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/infinitopes-granted-phase-1/2a-clinical-trial-application-approval 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/targeted-breast-cancer-pill-capivasertib-truqap-approved-use-nhs 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/support-new-test-monitor-people-risk-multiple-myeloma 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/first-treatment-common-bladder-cancer-recommended-nice 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/enedra-therapeutics-secures-financing-advance-drug-discovery-programmes 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-and-royal-surrey-partner-health-triage-advance-ai 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-appoints-clinical-advisory-board 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/innovation-and-entrepreneurship-awards-2025 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/storm-therapeutics-announces-first-patient-dosed-clinical-collaboration 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/artios-pharma-appoints-michael-t-andriole-ceo-and-director-advance 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/akamis-bio-announces-appointment-andrew-hirsch-companys-board-directors 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/myricx-bio-appoints-penny-fatato-global-head-clinical-operations-it 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cyted-health-secures-44m-series-b-financing-accelerate-us-expansion 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-nxera-pharma-announce-first-patient-dosed-phase-2a 2026-02-23T11:49:43+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/novalgen-begin-worlds-first-clinical-trial-self-regulating-immunotherapy 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/c-further-announces-major-partnership-gosh-charity-drive-innovation 2025-12-18T10:58:25+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/aim-medical-robotics-secures-81m-series-financing-transform-neurosurgery 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/artios-receives-us-fda-fast-track-designation-alnodesertib-atm-negative 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/adc-innovator-myricx-bio-appoints-boston-based-mohit-rawat-ceo-and-expands 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/trogenix-announces-ps70m-series-financing-drive-clinical-development 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-grand-challenges-shortlist-twelve-teams-tackle-cancers-toughest 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-presents-data-successfully-completed-phase-1-clinical 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/akamis-bio-receives-fda-fast-track-designation-ng-350a-treatment-mismatch 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/artios-announces-oversubscribed-115m-series-d-financing-accelerate 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/laigo-bio-raises-eu115m-seed-financing-advance-its-suretactm-targeted 2025-12-04T09:21:48+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/adc-therapeutics-announces-updated-data-lotis-7-phase-1b-clinical-trial 2025-12-05T13:32:19+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/alethio-therapeutics-launches-new-ceo-and-chair-advance-two-targeted 2025-12-05T13:30:27+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/enedra-therapeutics-appoints-dr-adrian-ibrahim-chief-executive-officer-0 2026-01-14T10:21:56+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cytoprime2-study-proves-effectiveness-endosignr-capsule-sponge-test 2025-12-05T16:55:29+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/aleta-biotherapeutics-and-cancer-research-uk-announce-promising-phase-1/2 2026-02-23T11:47:08+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/carrick-therapeutics-announces-positive-results-phase-2-randomised-trial 2025-12-15T15:53:13+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-and-incyte-collaborate-antibody-discovery-tackle 2026-01-13T08:03:57+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/infinitopes-expands-seed-financing-35m-accelerate-clinical-development 2026-01-21T14:01:31+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/altx-therapeutics-launches-slingshot-accelerator-ps1255m-funding 2026-02-05T09:31:37+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-makes-one-largest-oesophageal-cancer-datasets 2026-02-17T08:03:57+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/report-sets-out-how-ukri-can-set-more-spin-outs-success 2026-02-06T15:36:29+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/artios-receives-us-fda-fast-track-designation-dna-polymerase-theta-polth 2026-02-26T16:03:48+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/c-further-unveils-first-therapeutic-programmes-dedicated-paediatric 2026-03-17T14:14:27+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-novalgen-dose-first-patient-phase-1-trial-t-cell 2026-03-17T14:11:05+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/laigo-bio-completes-final-close-oversubscribed-seed-financing-eu17-million 2026-04-15T16:26:48+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-horizons-appoints-new-board-members-drive-translational 2026-05-06T15:46:40+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/trogenix-announces-publication-breakthrough-pre-clinical-data-nature 2026-04-09T14:15:43+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/storm-therapeutics-secures-56-million-series-c-financing-and-doses-first 2026-04-27T13:52:19+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/ucb-cancer-research-uk-and-cancer-research-horizons-announce-new-strategic 2026-05-07T09:14:11+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news/trogenix-doses-first-patient-phase-i/ii-clinical-trial-tgx-007-gene 2026-05-28T10:51:18+01:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/first-class-ikk-alpha-selective-compounds 2026-03-02T16:06:42+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/first-class-therapeutic-candidate-antibody-inhibiting 2026-03-02T15:51:33+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/4-1bb-multi-functional-monoclonal-antibodies-stimulating 2026-03-02T15:53:04+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/novel-tcr-treatment-nasopharyngeal-carcinoma 2026-03-02T15:58:22+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/antibody-drug-conjugates-targeting-clec14a 2026-03-02T16:08:06+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/best-2-and-best-3-trial-images 2026-03-02T16:09:08+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/optimam-mammography-image-database-omi-db 2026-03-30T15:31:00+01:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/oracle-diagnostic-cancer-prognosis 2026-03-02T15:50:28+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/cox-2-signature-novel-pan-cancer-treatment-response 2026-03-02T16:10:13+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/integrin-avb6-binding-peptides-tumour-targeting-imaging 2026-03-02T16:34:40+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/ibis-software-incorporating-tyrer-cuzick-model 2026-03-02T16:13:35+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/glutaminase-inhibitors 2026-03-02T15:21:38+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/small-molecule-cdc7-inhibitors 2026-03-02T15:32:49+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/novel-apelin-receptor-antagonist 2026-03-02T15:35:52+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/t-cell-extrect 2026-03-02T15:37:25+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/pcf-select-ctdna-targeted-sequencing-panel-1 2026-03-02T15:38:28+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/eclipse 2026-03-02T15:39:24+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/trimeric-cell-penetrating-peptides-intracellular-delivery 2026-03-02T15:40:18+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/multi-omic-clinically-linked-colorectal-cancer-database 2026-03-02T16:31:46+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/evotest 2026-03-02T15:42:30+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/theranostic-radiopharmaceutical-platform 2026-03-02T15:43:35+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/germline-panel-prostate-cancer 2026-03-02T15:44:28+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/liquid-biopsy-precision-radiotherapy 2026-03-02T15:46:59+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/full-transcriptomes-single-cell-rna-seq 2026-03-02T15:48:17+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/cd74-biomarker-immunotherapy-responsiveness-cancer 2026-03-02T15:49:26+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/real-world-lung-cancer-dataset 2026-05-29T09:52:48+01:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/antibody-clamp-enhanced-immunotherapy-agonism 2026-03-02T16:40:10+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities/oesophageal-cancer-clinical-and-molecular-stratification 2026-03-02T16:26:13+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/monika-gullerova-scientist-first-and-foremost 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/jason-mellad-co-founder-and-ceo 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/anna-perdrix-rosell-biotech-co-founder-and-managing-director 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/parp-inhibitors-halting-cancer-halting-dna-repair 2026-05-06T11:53:32+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/how-uk-researchers-commercialised-cd25-immunotherapy-drug-target 2026-05-06T11:52:45+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/taking-dna-repair-tackle-cancer 2026-05-06T11:51:18+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/speaking-thousand-words-how-cancer-image-collection-set-improve-ai-diagnosis 2026-05-06T11:51:35+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/coming-together-zynlonta 2026-05-06T11:51:58+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/new-approach-cancer-immunotherapy 2026-05-06T11:50:52+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/smart-knives-virtual-reality-tumours-five-innovations-understanding-cancer 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/new-culture-how-cruk-helping-take-organoids-global 2026-05-06T11:49:24+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/mov18-opening-new-front-immunotherapy 2026-05-06T11:42:35+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/switch-and-trojan-horse-how-viral-vectors-and-synthetic-enhancers-could-change-glioblastoma 2026-05-06T11:23:28+01:00 0.5 https://www.cancerresearchhorizons.com/home-page 2026-06-02T16:12:25+01:00 0.5 https://www.cancerresearchhorizons.com/page-not-found 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/partners/medtech-and-diagnostics 2026-05-27T11:42:38+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people 2026-04-07T15:16:04+01:00 0.5 https://www.cancerresearchhorizons.com/partners/our-partnerships 2026-05-21T12:13:55+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-reports-and-corporate-responsibility/our-annual-reviews 2026-05-06T14:48:01+01:00 0.5 https://www.cancerresearchhorizons.com/our-translational-science/functional-genomics-centre 2026-05-20T15:59:27+01:00 0.5 https://www.cancerresearchhorizons.com/investors 2026-05-21T11:59:51+01:00 0.5 https://www.cancerresearchhorizons.com/researchers/protect-your-innovation 2026-05-20T15:25:03+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events 2026-05-21T12:03:29+01:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio 2026-05-21T11:57:29+01:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-pipeline 2026-05-21T10:59:43+01:00 0.5 https://www.cancerresearchhorizons.com/our-translational-science 2026-05-20T15:46:47+01:00 0.5 https://www.cancerresearchhorizons.com/our-translational-science/our-drug-discovery-science 2026-05-06T11:12:35+01:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-licensing-opportunities 2026-05-21T13:00:19+01:00 0.5 https://www.cancerresearchhorizons.com/about-us 2026-05-27T12:01:43+01:00 0.5 https://www.cancerresearchhorizons.com/researchers/entrepreneurial-training/accelerate-your-idea 2026-05-20T15:32:26+01:00 0.5 https://www.cancerresearchhorizons.com/modern-slavery-statement 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/section-172-statement 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/researchers 2026-05-20T15:15:23+01:00 0.5 https://www.cancerresearchhorizons.com/researchers/entrepreneurial-training 2026-05-18T15:53:50+01:00 0.5 https://www.cancerresearchhorizons.com/researchers/entrepreneurial-training/start-your-entrepreneurial-journey 2026-05-20T15:26:11+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-impact 2026-06-03T09:01:39+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-boards 2026-06-03T09:03:47+01:00 0.5 https://www.cancerresearchhorizons.com/partners 2026-05-21T12:10:45+01:00 0.5 https://www.cancerresearchhorizons.com/researchers/set-and-build-your-start 2026-05-20T16:39:34+01:00 0.5 https://www.cancerresearchhorizons.com/researchers/access-funding/our-translation-fund 2026-05-06T11:20:51+01:00 0.5 https://www.cancerresearchhorizons.com/terms-conditions 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/our-privacy-policy 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/cookie-policy 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/legal-status 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-success-stories 2026-05-21T12:02:07+01:00 0.5 https://www.cancerresearchhorizons.com/researchers/access-funding/cancer-research-horizons-seed-fund 2026-05-20T15:12:39+01:00 0.5 https://www.cancerresearchhorizons.com/investors/our-seed-fund 2026-05-21T11:40:15+01:00 0.5 https://www.cancerresearchhorizons.com/investors/donating-cancer-impact-booster 2026-05-21T11:41:29+01:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/our-start-up-portfolio 2026-05-20T16:54:07+01:00 0.5 https://www.cancerresearchhorizons.com/kudos-pharmaceuticals 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/spirogen 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/gamma-delta-therapeutics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/adaptate-biotherapeutics 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/partners/data-partnerships/our-guiding-principles-data-partnerships 2026-05-21T13:35:31+01:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/cancertools 2026-05-21T11:46:20+01:00 0.5 https://www.cancerresearchhorizons.com/researchers/access-funding/data-catalyst 2026-05-21T13:36:16+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-media 2026-05-21T12:07:52+01:00 0.5 https://www.cancerresearchhorizons.com/de-risking-oncology-development 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/our-media/advances-drug-discovery-and-development 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/our-media/cancer-immunotherapies-landscape-challenges-and-future 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/cancer-research-academic/industry-interface 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/determine-trial-showcasing-cancer-research-uks-unique-position-pharma-industry 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/chemistry-steroids-how-we-developed-our-expertise-steroid-hydroxylation-chemistry 2026-05-06T11:48:54+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles 2026-05-20T16:13:08+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/functional-genomics-centre-building-single-cell-crispr-capability 2026-05-06T11:44:53+01:00 0.5 https://www.cancerresearchhorizons.com/Media/using-pooled-crispr-screening-drive-oncology-drug-discovery 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/emerging-new-drug-class-nearly-wasnt 2026-05-06T11:44:17+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/uk-spinout-review-moving-beyond-equity 2026-05-06T11:42:55+01:00 0.5 https://www.cancerresearchhorizons.com/our-translational-science/functional-genomics-centre/our-functional-genomics-centre-team 2026-05-20T16:14:21+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-reports-and-corporate-responsibility/gender-and-ethnicity-pay-gap-reports 2026-05-06T14:50:57+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/power-commercial-data-partnerships 2026-05-06T11:42:13+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/international-womens-day-2024 2026-05-06T11:41:50+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/beyond-borders-going-global-clinical-trials 2026-05-06T11:41:20+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/horizon-exploring-investment-trends 2026-05-06T11:41:07+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/pentabind-revolutionising-drug-discovery-ai-enhanced-aptamers 2026-05-06T11:40:53+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/gambitbio-empowering-early-detection-home 2026-05-06T11:40:30+01:00 0.5 https://www.cancerresearchhorizons.com/innovation-summit 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/carcinotech-3d-printing-living-tumours 2026-05-06T11:40:13+01:00 0.5 https://www.cancerresearchhorizons.com/our-ventures-team 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/our-therapeutic-innovation-team 2026-06-03T16:14:09+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/our-search-and-evaluation-team 2026-03-09T08:36:55+00:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/our-business-development-team 2026-03-27T15:36:47+00:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/our-business-operations-team 2026-03-20T08:53:00+00:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-reports-and-corporate-responsibility 2026-05-06T14:41:28+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/careers 2026-05-20T15:50:33+01:00 0.5 https://www.cancerresearchhorizons.com/researchers/access-funding 2026-05-20T15:34:55+01:00 0.5 https://www.cancerresearchhorizons.com/researchers/our-community-entrepreneurs 2026-05-20T16:41:19+01:00 0.5 https://www.cancerresearchhorizons.com/our-translational-science/cancer-research-uk-centre-drug-development 2026-05-20T16:00:34+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-news 2026-05-21T12:04:58+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/events 2026-05-14T14:59:19+01:00 0.5 https://www.cancerresearchhorizons.com/innovation-and-entrepreneurship-awards-0 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/events/innovation-and-entrepreneurship-awards/winners-and-nominees 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/contact-us 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/economics-stack-its-perfect-time-innovate-cancer-research 2026-05-06T11:50:24+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/building-crispr-database 2026-05-06T11:39:58+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/dotplot-user-centric-approach-early-detection 2026-05-06T11:31:07+01:00 0.5 https://www.cancerresearchhorizons.com/innovation-summit/innovation-summit-2024-sessions 2026-05-20T17:02:33+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/whats-on-the-industrys-horizon 2026-05-06T11:30:06+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/putting-med-translational-medicine 2026-05-06T11:28:29+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/four-women-driving-innovation-cancer-treatment 2026-05-06T11:28:58+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/jpm-2025-key-takeaways-largest-healthcare-investment-conference 2026-05-06T11:29:42+01:00 0.5 https://www.cancerresearchhorizons.com/investors/donating-cancer-impact-booster/cancer-impact-club 2026-05-21T11:43:40+01:00 0.5 https://www.cancerresearchhorizons.com/you-have-answered-a 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/you-have-answered-b 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/you-have-answered-c 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/inner-city-detroit-aacr-president 2026-05-06T11:28:01+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/turning-ideas-innovations 2026-05-06T11:25:44+01:00 0.5 https://www.cancerresearchhorizons.com/our-portfolio/data-portfolio 2026-05-28T17:18:20+01:00 0.5 https://www.cancerresearchhorizons.com/partners/data-partnerships 2026-05-21T13:34:45+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-expert-network 2026-05-06T14:52:49+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/on-the-horizon-extrachromosomal-dna 2026-05-06T11:26:59+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/pathway-bio-redefining-precision-medicine 2026-05-06T11:26:21+01:00 0.5 https://www.cancerresearchhorizons.com/innovation-summit/2024-edition 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/building-trust-cancer-ai-starts-better-data 2026-05-06T11:26:44+01:00 0.5 https://www.cancerresearchhorizons.com/search 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/bridge-over-river-tyne-cross-sector-collaboration-newcastle-university 2026-05-06T11:25:27+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/natalie-mount-lab-bench-boardroom 2026-05-06T11:25:02+01:00 0.5 https://www.cancerresearchhorizons.com/innovation-summit/2025-edition 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/innovation-summit/2025-edition/sessions 2025-12-03T10:41:46+00:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/harnessing-power-ecosystem-innovation-summit 2026-05-06T11:24:34+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/making-cancer-history-interview-tim-yap 2026-05-06T11:23:12+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/minding-gap-there-ever-perfect-time-launch-start 2026-05-06T11:22:47+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/idea-impact-interview-jessica-corry 2026-05-06T11:22:15+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/deepening-university-investor-links-what-new-ukri-report-means-research-translation 2026-05-06T11:22:30+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/in-search-of-the-missing-link 2026-05-06T11:20:19+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/minding-gap-what-does-chinas-biotech-boom-mean-uk 2026-05-06T11:21:18+01:00 0.5 https://www.cancerresearchhorizons.com/news-and-events/our-articles/rise-alternative-investors-oncology-innovation 2026-05-06T11:17:53+01:00 0.5 https://www.cancerresearchhorizons.com/getting-patients-interview-lillian-siu 2026-05-06T11:16:59+01:00 0.5 https://www.cancerresearchhorizons.com/taking-unique-challenges-paediatric-cancer 2026-04-30T15:36:26+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/hamish-ryder 2026-05-20T16:59:13+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/jennifer-mckelvie 2026-04-08T15:22:42+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/neil-jones 2026-04-08T15:26:09+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/rachel-grimley 2026-04-08T15:20:54+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/stuart-farrow 2026-04-08T15:19:43+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/steve-wedge 2026-04-08T15:20:38+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/tony-hickson 2026-04-08T15:20:16+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/phil-masterson 2026-04-08T15:21:17+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/iain-foulkes 2026-04-08T15:11:47+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/peter-chambre 2026-04-08T15:21:25+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/andy-richards 2026-04-08T15:25:15+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/gillian-fairfield 2026-04-08T15:23:13+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/olivia-cavlan 2026-04-08T15:21:51+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/alex-badamchi-zadeh 2026-04-08T15:25:08+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/alessia-errico 2026-04-08T15:25:00+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/george-tzircotis 2026-04-08T15:24:33+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/robert-bondaryk 2026-04-08T15:20:46+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/tanya-moore 2026-04-08T15:20:23+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/vishal-gulati 2026-04-08T15:20:00+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/annalisa-jenkins 2026-04-21T12:53:50+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/christoph-lengauer 2026-04-08T15:25:35+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/kevin-doyle 2026-04-08T15:24:20+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/jonathan-tobin 2026-04-08T15:22:35+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/genghis-lloyd-harris 2026-04-08T15:23:21+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/douglas-ross-thriepland 2026-04-08T15:23:56+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/david-walter 2026-04-08T15:25:41+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/ultan-mcdermott 2026-04-08T15:24:26+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/carlos-garcia-echeverria 2026-04-21T12:55:38+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/katharina-kreymborg 2026-04-21T12:57:11+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/karen-lackey 2026-04-21T12:57:55+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/torquil-jackson 2026-04-08T15:20:07+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/tanya-hughes 2026-04-08T15:20:31+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/esme-walters 2026-04-08T15:23:29+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/gregor-lawrence 2026-04-08T15:23:05+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/agnes-martin 2026-04-08T15:26:01+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/nick-tribble 2026-04-08T15:21:59+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/katie-sloan 2026-04-08T15:22:08+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/isabel-herriett 2026-04-08T15:22:50+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/oliver-rughani-hindmarch 2026-04-08T15:23:47+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/hitesh-thakrar 2026-04-21T12:49:48+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/andrea-schievella 2026-04-08T15:19:14+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/heather-preston 2026-04-21T12:39:53+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/richard-wooster 2026-04-21T12:41:59+01:00 0.5 https://www.cancerresearchhorizons.com/about-us/our-people/hans-bishop 2026-04-21T12:43:09+01:00 0.5